Small Lymphocytic Leukemia Clinical Trials

15 clinical trials for Small Lymphocytic Leukemia across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL — RECRUITING · PHASE3
• Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Time-limited Treatment for Patients With Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL). — RECRUITING · PHASE2
• Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL) — RECRUITING · PHASE2
• REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy — COMPLETED
• BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I) — COMPLETED · PHASE1
• Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL) — COMPLETED · PHASE2
• Acalabrutinib in Combination With R-ICE For Relapsed or Refractory Lymphoma — TERMINATED · PHASE2
• A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies — COMPLETED · PHASE1
• A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia) — COMPLETED
• Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — COMPLETED · PHASE1
• Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL — TERMINATED · PHASE1
• Duvelisib for Ibrutinib-Resistant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — TERMINATED · PHASE2
• Dose Escalation Study of Revlimid With Fludarabine-Rituximab for CLL/SLL — TERMINATED · PHASE1
• Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphocytic Lymphoma — WITHDRAWN · PHASE1
• Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia — OTHER · PHASE1

Refine this search